News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,930 Results
Type
Article (42567)
Company Profile (296)
Press Release (695048)
Multimedia
Podcasts (103)
Webinars (24)
Section
Business (206721)
Career Advice (2070)
Deals (35848)
Drug Delivery (136)
Drug Development (82112)
Employer Resources (174)
FDA (16608)
Job Trends (15142)
News (349694)
Policy (33024)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2649)
Accelerated approval (47)
Adcomms (29)
Allergies (173)
Alliances (50290)
ALS (214)
Alzheimer's disease (1828)
Antibody-drug conjugate (ADC) (454)
Approvals (16989)
Artificial intelligence (685)
Autoimmune disease (297)
Automation (60)
Bankruptcy (367)
Best Places to Work (11734)
BIOSECURE Act (21)
Biosimilars (223)
Biotechnology (188)
Bladder cancer (197)
Brain cancer (72)
Breast cancer (755)
Cancer (5870)
Cardiovascular disease (474)
Career advice (1756)
Career pathing (42)
CAR-T (338)
CDC (59)
Celiac Disease (3)
Cell therapy (922)
Cervical cancer (47)
Clinical research (71277)
Collaboration (2121)
Company closure (5)
Compensation (1407)
Complete response letters (81)
COVID-19 (2803)
CRISPR (110)
C-suite (1165)
Cystic fibrosis (154)
Data (7967)
Decentralized trials (3)
Denatured (35)
Depression (172)
Dermatology (88)
Diabetes (588)
Diagnostics (6992)
Digital health (57)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (334)
Drug pricing (207)
Drug shortages (31)
Duchenne muscular dystrophy (285)
Earnings (92409)
Editorial (68)
Employer branding (21)
Employer resources (153)
Events (120565)
Executive appointments (1112)
FDA (20364)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1776)
Gene editing (241)
Generative AI (59)
Gene therapy (740)
GLP-1 (1074)
Government (4790)
Grass and pollen (6)
Guidances (408)
Healthcare (19130)
HIV (81)
Huntington's disease (59)
IgA nephropathy (97)
Immunology and inflammation (297)
Immuno-oncology (95)
Indications (195)
Infectious disease (3147)
Inflammatory bowel disease (220)
Inflation Reduction Act (16)
Influenza (137)
Intellectual property (294)
Interviews (325)
IPO (16742)
IRA (54)
Job creations (3709)
Job search strategy (1461)
JPM (59)
Kidney cancer (19)
Labor market (101)
Layoffs (584)
Leadership (39)
Legal (8013)
Liver cancer (101)
Longevity (33)
Lung cancer (769)
Lymphoma (429)
Machine learning (61)
Management (59)
Manufacturing (1086)
MASH (189)
Medical device (14027)
Medtech (14153)
Mergers & acquisitions (20367)
Metabolic disorders (1516)
mRNA (213)
Multiple sclerosis (188)
NASH (17)
Neurodegenerative disease (430)
Neuropsychiatric disorders (111)
Neuroscience (3370)
Neurotech (1)
NextGen: Class of 2026 (6604)
Non-profit (4564)
Now hiring (78)
Obesity (711)
Opinion (300)
Ovarian cancer (221)
Pain (259)
Pancreatic cancer (307)
Parkinson's disease (368)
Partnered (36)
Patents (600)
Patient recruitment (676)
Peanut (63)
People (60330)
Pharmaceutical (61)
Pharmacy benefit managers (32)
Phase 1 (22205)
Phase 2 (31422)
Phase 3 (23360)
Pipeline (8851)
Policy (325)
Postmarket research (2584)
Preclinical (9476)
Press Release (65)
Prostate cancer (305)
Psychedelics (59)
Radiopharmaceuticals (331)
Rare diseases (1096)
Real estate (6075)
Recruiting (71)
Regulatory (25618)
Reports (56)
Research institute (2455)
Resumes & cover letters (360)
Rett syndrome (40)
RNA editing (26)
RSV (88)
Schizophrenia (181)
Series A (304)
Series B (219)
Service/supplier (14)
Sickle cell disease (112)
Special edition (25)
Spinal muscular atrophy (167)
Sponsored (48)
Startups (3733)
State (2)
Stomach cancer (18)
Supply chain (129)
Tariffs (90)
The Weekly (66)
Vaccines (1111)
Venture capital (110)
Weight loss (459)
Women's health (130)
Worklife (20)
Date
Today (159)
Last 7 days (847)
Last 30 days (3692)
Last 365 days (30630)
2026 (12926)
2025 (30545)
2024 (35518)
2023 (40370)
2022 (51539)
2021 (56075)
2020 (54481)
2019 (46995)
2018 (35354)
2017 (32432)
2016 (31827)
2015 (37913)
2014 (31609)
2013 (26664)
2012 (28919)
2011 (29564)
2010 (27616)
Location
Africa (759)
Alabama (94)
Alaska (7)
Arizona (350)
Arkansas (14)
Asia (40219)
Australia (6619)
California (13425)
Canada (3783)
China (1357)
Colorado (572)
Connecticut (584)
Delaware (412)
Europe (87544)
Florida (2006)
Georgia (432)
Hawaii (3)
Idaho (64)
Illinois (1066)
India (92)
Indiana (607)
Iowa (24)
Japan (542)
Kansas (136)
Kentucky (51)
Louisiana (42)
Maine (76)
Maryland (1604)
Massachusetts (9574)
Michigan (366)
Minnesota (728)
Mississippi (6)
Missouri (146)
Montana (34)
Nebraska (29)
Nevada (146)
New Hampshire (85)
New Jersey (3506)
New Mexico (30)
New York (3507)
North Carolina (1727)
North Dakota (10)
Northern California (6733)
Ohio (405)
Oklahoma (23)
Oregon (43)
Pennsylvania (2685)
Puerto Rico (29)
Rhode Island (50)
South America (1126)
South Carolina (86)
South Dakota (2)
Southern California (5290)
Tennessee (216)
Texas (2154)
United States (47373)
Utah (401)
Vermont (1)
Virginia (325)
Washington D.C. (81)
Washington State (1089)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
737,930 Results for "scale biosciences inc aka scalebio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neurocrine Biosciences Announces Publication Establishing Clinically Meaningful Improvement Threshold for the Tardive Dyskinesia Impact Scale
April 29, 2026
·
14 min read
IN PARTNERSHIP WITH AGC BIOLOGICS
Your Scale, Your Terms: How Modular Bioreactors Are Redefining Capacity & Manufacturing Strategies
Principal Scientist Anders Cai Holm Hansen explains how CDMO AGC Biologics uses its global, single-use network and a strategy emphasizing “scale-out” manufacturing, to derisk demand uncertainty, speed timelines and conserve cash for emerging drug developers.
April 13, 2026
·
7 min read
·
Jennifer C. Smith-Parker
Business
Vizgen and Scale Biosciences Unveil Strategic Partnership at AGBT
Vizgen, Inc. has announced a partnership with Scale Biosciences (ScaleBio) to combine their single-cell and spatial technologies for enhanced data analysis at the Advances in Genome Biology and Technology (AGBT) 2024 General Meeting in Orlando, Florida.
February 5, 2024
·
3 min read
Biotech Beach
Scale Biosciences Announces Progress Across Growing Portfolio of Single-Cell Omics Solutions
Scale Biosciences today announced the availability of three new datasets showcasing the performance of its newly released products, including the ScaleBio Single Cell Methylation Kit, ScaleBio Single Cell RNA Kit v1.1 with extended throughput, and ScaleBio CRISPR Guide Enrichment Kit, all of which are now shipping.
January 8, 2024
·
3 min read
Insights
Can Europe turn world-class science into world-class scale?
Despite exceptional regional hubs and research strength, investors say Europe still needs more integrated incubators, smarter regulation and broader pools of patient capital to keep breakthrough companies growing at home.
April 16, 2026
·
5 min read
·
Jennifer C. Smith-Parker
Press Releases
Benchling Biologics delivers no-code antibody format design and automated registration at scale
May 11, 2026
·
5 min read
Press Releases
Made Scientific Strengthens Board to Support Scale-Up and Commercial Readiness in Cell Therapy Manufacturing
April 30, 2026
·
4 min read
Vaccines
Pesky ‘Macro Factors’—aka RFK Jr.—Come for Vaccine Pharmas’ Wallets
Following restricted vaccine approvals and changes to CDC immunization schedules, Merck, Pfizer, GSK and Sanofi are all suffering revenue hits to their vaccine programs.
November 7, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
Bora Biologics Successfully Completes 2,000L Engineering and Scale-Up Run in San Diego, Reinforcing Commercial-Scale Readiness
April 6, 2026
·
4 min read
Press Releases
Arna Pharma Inc. and Slate Run Pharmaceuticals to form a Joint Venture to Create Scaled-Up U.S. Specialty Pharmaceutical Platform
February 26, 2026
·
3 min read
1 of 73,793
Next
